Back to results
US 6,586,429 B2Granted
Tricyclic fused xanthine compounds and their uses
AssigneeCell Therapeutics, Inc.
InventorsBaoqing Gong, J. Peter Klein, Michael Coon
Life of this patent
Estimating the term…
Abstract
Novel tricyclic compounds are found to be useful for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling. The compounds have the following formulas where R1, R2 and R3 are defined in the written description of the invention.
Claims8
A compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, selected from the group consisting of:
A compound having the following formula:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.